Laurion Capital Management LP
Position in ABOS — Acumen Pharmaceuticals, Inc.
CIK 1390202
NEW YORK, NY
Position in ABOS
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$1,240,047
-$589,420 QoQ
Shares Held
525,444
-39.4% QoQ
Ownership
0.727%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#16
of 84 holders
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ABOS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Laurion Capital Management LP holds $248,360,790 across 18 Biotechnology names. ABOS ranks #15 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
|
1,262,651 | $93,764,463 | |
| 2 | MLYS |
Mineralys Therapeutics, Inc.
|
2,232,040 | $60,465,963 | |
| 3 | NUVB |
Nuvation Bio Inc.
|
7,822,638 | $33,559,117 | |
| 4 | BBOT |
BridgeBio Oncology Therapeutics, Inc.
|
1,922,656 | $17,207,771 | |
| 5 | PYXS |
Pyxis Oncology, Inc.
|
4,997,333 | $7,296,106 | |
| 6 | VOR |
Vor Biopharma Inc.
|
318,670 | $5,685,072 | |
| 7 | PEPG |
PepGen Inc.
|
2,750,855 | $4,869,013 | |
| 8 | AUTL |
Autolus Therapeutics plc
|
3,316,626 | $4,576,943 |
All Filings in ABOS
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,240,047 | 525,444 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,829,467 | 867,046 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,482,648 | 867,046 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $1,005,773 | 867,046 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $953,750 | 867,046 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,491,319 | 867,046 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,150,274 | 867,046 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,851,577 | 1,178,338 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $7,674,843 | 1,895,023 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $7,276,888 | 1,895,023 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $7,864,345 | 1,895,023 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $5,803,495 | 1,206,548 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $4,898,584 | 1,206,548 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $6,515,359 | 1,206,548 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $12,101,676 | 1,206,548 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $5,670,775 | 1,206,548 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,568,275 | 656,848 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $4,440,292 | 656,848 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $9,760,761 | 656,848 | Shares | Sole | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||